BASF to expand fungicide facilities in Germany and US


BASF is planning to invest more than €200m in order to scale up and integrate production and formulation capacities, to meet rising demands for several key fungicides, including F 500 and Xemium.

"The investment is one of the division's largest capital investments in recent years, according to the company."

As part of the investment, the company will expand its facilities in Schwarzheide and Ludwigshafen, Germany, as well as its US facility in Sparks, Georgia.

The investment is one of the division's largest capital investments in recent years, according to the company.

Markus Heldt, BASF crop protection division president, said the company expects a strong market demand for its product portfolio in the future.

''That is why we increased the estimated peak sales potential of our pipeline to €2.8bn earlier this year," Heldt added.

"These investments will help to increase our operating efficiency and flexibility, so that we can continue to contribute to sustainable agriculture through our innovative solutions for farmers around the world."

BASF's fungicide portfolio includes F 500, AgCelence and Xemium. BASF expects the sales of F 500 and Xemium to be around €1bn and €200m respectively.